Are collagen peptides the same thing as hydrolysed collagen?

Largely yes, in commercial practice. Both terms describe collagen protein that has been broken down — hydrolysed — into shorter peptide fragments. 'Collagen hydrolysate' describes the process; 'collagen peptides' describes the product. Some manufacturers use the terms interchangeably, and for most regulatory and research purposes they refer to the same material, provided the molecular weight distribution is similar.

How are collagen peptides regulated in Australia — are they medicines or food?

It depends on how they're sold and labelled. Collagen peptides sold as a food ingredient or general food supplement are regulated under Food Standards Australia New Zealand (FSANZ) frameworks and are not scheduled substances under the Poisons Standard. If a product makes therapeutic claims — that is, claims to treat, prevent or cure a condition — it may be classified as a therapeutic good and would need to be listed or registered on the Australian Register of Therapeutic Goods (ARTG), with all the associated TGA requirements that entails.

Do collagen peptides actually survive digestion and get absorbed intact?

Some do, in small amounts. Research has detected specific Hyp-containing dipeptides and tripeptides (such as Pro-Hyp and Hyp-Gly) in human blood plasma after oral ingestion of collagen hydrolysates, peaking around 1–2 hours post-dose. The concentrations are low — nanomolar to low micromolar — and the biological significance of these circulating fragments in humans remains under investigation. The short version: some peptide sequences survive transit and appear systemically, but this is a mechanistic observation, not a clinical outcome.

Does the source of collagen (marine vs bovine) make a difference to the peptides?

It can, modestly. Marine-sourced collagen (typically from fish skin or scales) tends to produce hydrolysates with a lower average molecular weight than bovine-sourced material, partly due to biological differences and partly due to processing. Amino acid profiles also differ slightly. For consumers with dietary restrictions around pork or beef, source matters independently of any pharmacokinetic consideration. Beyond that, the evidence directly comparing clinical outcomes by source is limited.

Are collagen peptides the same as the injectable peptides the TGA has been cracking down on?

No. The TGA's enforcement actions around unapproved peptides have targeted synthetic, injectable peptides — particularly those marketed for body composition or performance purposes — that do not hold approval as therapeutic goods in Australia. Collagen peptides are food-derived, orally consumed, and typically regulated as food ingredients or listed complementary medicines, not as scheduled or controlled substances. They are a distinct peptide class with a very different regulatory and clinical profile.

Collagen Peptides as Food Supplements

By Priya Nandakumar · 3 July 2026 · 7 min read

Abstract blobs and shapes of various colors.

What collagen peptides actually are, chemically speaking

Roughly 30% of total protein mass in the human body is collagen. That figure alone tells you why this structural protein gets so much scientific attention , and also why the supplement industry got interested early and loudly. The noise from that industry has, honestly, made it harder to have a clean conversation about the underlying chemistry. So let's start there.

Collagen is a fibrous protein built from repeating tripeptide sequences, classically Gly-X-Y (glycine at every third position, with proline and hydroxyproline frequently occupying the X and Y slots). These chains coil into a right-handed triple helix. It's one of the more elegant molecular structures in connective tissue biology , three chains wound together, stabilised by interchain hydrogen bonds and the steric constraints imposed by that glycine residue.

Collagen peptides are what you get when that intact collagen protein is hydrolysed: enzymatic or acid/alkali treatment cleaves the peptide bonds between amino acid residues, yielding short fragments , typically 2 to 20 amino acids in length, with an average molecular weight around 3–5 kDa depending on the manufacturing process. The resulting mixture is predominantly dipeptides and tripeptides, with the characteristic Hyp-Gly and Pro-Hyp-Gly sequences appearing frequently. These are sometimes called "hydrolysed collagen" or "collagen hydrolysate" interchangeably with collagen peptides, though strictly speaking the terms describe the same product class.

Gelatin sits in between: it's partially hydrolysed collagen, denatured but not fully broken down. Collagen peptides are the next step; smaller, more water-soluble, and with different absorption kinetics.

Where collagen peptides sit in the broader peptide classification

If you've read our overview of what a peptide is, you'll know the category spans an enormous structural range, from two-residue dipeptides up to chains approaching 50 residues, beyond which we generally call something a protein. Collagen peptides sit firmly at the smaller end of that spectrum, and that size is relevant to how they're absorbed.

Unlike many peptide classes discussed in this section of the site, such as the injectable GLP-1 receptor agonists, which are Schedule 4 prescription-only medicines in Australia and require a valid prescription to access legally; collagen peptides are classified as food ingredients. That regulatory distinction matters enormously in practice, and I'll come to it shortly.

Structurally, collagen-derived peptides are not cyclic, not lipidated, and carry no unusual non-canonical amino acids. They're about as straightforward as peptides get. That simplicity is part of why they can be delivered orally without the stability concerns that plague many other peptide classes.

Absorption and pharmacokinetics: what happens after you swallow them

This is the part that actually interests me most, the pharmacokinetics. For a long time the assumption was that orally ingested peptides would just be digested back to free amino acids in the gut, making the specific peptide sequences irrelevant. A few studies across the 2010s complicated that picture.

Research published in the Journal of Agricultural and Food Chemistry (Iwai et al., 2005, later replicated in further Japanese cohort work) detected intact Pro-Hyp and Hyp-Gly dipeptides in human plasma after oral collagen hydrolysate ingestion, peaking at roughly 1–2 hours post-ingestion. Subsequent work by Shigemura et al. (2014) in Food Chemistry extended this, identifying additional Hyp-containing peptide fragments circulating in plasma. The concentrations are low, nanomolar to low micromolar range; and the clinical significance of circulating Hyp-containing peptides in humans remains an active area of investigation.

What is reasonably well-established at the mechanistic level: a subset of small collagen-derived peptides does survive intestinal digestion and appears transiently in systemic circulation. They are not, in the pharmacokinetic sense, equivalent to simply eating protein. Whether those circulating fragments do anything meaningful in peripheral tissues is a different question, and one the current literature hasn't settled cleanly. I'd be cautious about anyone claiming otherwise.

One confounding factor worth flagging: bioavailability data in this space is almost entirely from studies conducted on hydrolysates with specific molecular weight distributions, usually proprietary preparations. Extrapolating those findings to every collagen powder on a health food shelf isn't straightforward. Molecular weight distribution matters, and it varies.

Sources, types, and manufacturing

Commercial collagen peptides are derived from a handful of primary sources: bovine hide and bone, porcine skin, marine (predominantly fish skin and scales), and, less commonly; poultry. The source affects the amino acid profile modestly and has obvious relevance for consumers with dietary restrictions or religious considerations around pork or beef. Marine-sourced hydrolysates tend to have a lower average molecular weight than bovine, though this is as much a function of processing as species biology.

Hydrolysis is most commonly achieved with food-grade proteolytic enzymes (endopeptidases, exopeptidases, or combinations). The degree of hydrolysis, the enzyme specificity, and downstream filtration steps all shape the final peptide size distribution. This is worth knowing because "collagen peptides" on a label describes a class, not a single compound. Two products can carry the same name and have meaningfully different molecular profiles.

I was running along the Parramatta River foreshore a few weeks back, long run, the kind where you have too much time to think, and I found myself turning over exactly this point. The standardisation problem in food-supplement peptides is real, and it's one reason the research is hard to synthesise. If you're reading a study, checking the molecular weight profile of the hydrolysate used is worth your time.

Regulatory classification in Australia

Collagen peptides sold as food supplements in Australia are typically regulated as food ingredients or as listed complementary medicines on the Australian Register of Therapeutic Goods (ARTG). They are not classified under the Poisons Standard as scheduled substances. This distinguishes them sharply from many other peptides covered on this site.

For context: peptides marketed for performance or body composition purposes; think of the broader unapproved peptide category that the TGA has specifically targeted in enforcement actions, occupy a very different legal space. The TGA has been explicit and active here: supplying unapproved therapeutic goods, including many synthetic peptides, without authorisation is illegal under the Therapeutic Goods Act 1989. That enforcement posture has been strengthening, not softening.

Collagen peptides sold as food do not fall into that category, provided they are not making therapeutic claims on the label or in advertising. The moment a product starts claiming to treat, cure, or prevent a condition, it potentially becomes a therapeutic good under the Act and would need to meet the relevant registration or listing requirements on the ARTG. That's the regulatory line manufacturers walk, and sometimes cross.

Products listed on the ARTG as complementary medicines are assessed by the TGA, and sponsors are required to hold evidence for any permitted indications. Good Manufacturing Practice requirements apply to listed and registered therapeutic goods. Food products are regulated separately under Food Standards Australia New Zealand (FSANZ) frameworks. If a collagen peptide product sits in the grey zone between food and medicine in how it's marketed, that's where regulatory scrutiny tends to land.

What the research does and doesn't say

There is a body of peer-reviewed literature examining collagen peptide ingestion and various physiological markers; skin hydration, joint-related outcomes in specific populations, bone density markers. Some of that work is reasonably methodologically sound; some of it is funded by manufacturers with obvious interests. I'd encourage reading the full methods section of any trial in this area, not just the abstract, and checking whether the molecular weight profile of the specific hydrolysate is disclosed.

Systematic reviews, including a 2019 review by Choi et al. published in Molecules, have generally noted that while some studies show statistically significant findings on skin-related outcomes, trial heterogeneity (different products, different populations, different follow-up durations) makes pooled conclusions difficult. That's not unusual for food-component research. It means the literature is suggestive in places, not definitive.

What I'd push back on, and this is a personal view, is the tendency to read mechanistic plausibility as clinical proof. Yes, Hyp-containing peptides appear in plasma after ingestion. Yes, fibroblasts have receptors that respond to certain peptide ligands in vitro. But "mechanistically interesting" and "demonstrated clinical effect at real-world doses" are two different statements, and collapsing them is where supplement marketing tends to operate. The science deserves better framing than that.

Sources

, Priya Nandakumar, Pharmacology writer, peptides & PK

Common questions

Are collagen peptides the same thing as hydrolysed collagen?: Largely yes, in commercial practice. Both terms describe collagen protein that has been broken down — hydrolysed — into shorter peptide fragments. 'Collagen hydrolysate' describes the process; 'collagen peptides' describes the product. Some manufacturers use the terms interchangeably, and for most regulatory and research purposes they refer to the same material, provided the molecular weight distribution is similar.
How are collagen peptides regulated in Australia — are they medicines or food?: It depends on how they're sold and labelled. Collagen peptides sold as a food ingredient or general food supplement are regulated under Food Standards Australia New Zealand (FSANZ) frameworks and are not scheduled substances under the Poisons Standard. If a product makes therapeutic claims — that is, claims to treat, prevent or cure a condition — it may be classified as a therapeutic good and would need to be listed or registered on the Australian Register of Therapeutic Goods (ARTG), with all the associated TGA requirements that entails.
Do collagen peptides actually survive digestion and get absorbed intact?: Some do, in small amounts. Research has detected specific Hyp-containing dipeptides and tripeptides (such as Pro-Hyp and Hyp-Gly) in human blood plasma after oral ingestion of collagen hydrolysates, peaking around 1–2 hours post-dose. The concentrations are low — nanomolar to low micromolar — and the biological significance of these circulating fragments in humans remains under investigation. The short version: some peptide sequences survive transit and appear systemically, but this is a mechanistic observation, not a clinical outcome.
Does the source of collagen (marine vs bovine) make a difference to the peptides?: It can, modestly. Marine-sourced collagen (typically from fish skin or scales) tends to produce hydrolysates with a lower average molecular weight than bovine-sourced material, partly due to biological differences and partly due to processing. Amino acid profiles also differ slightly. For consumers with dietary restrictions around pork or beef, source matters independently of any pharmacokinetic consideration. Beyond that, the evidence directly comparing clinical outcomes by source is limited.
Are collagen peptides the same as the injectable peptides the TGA has been cracking down on?: No. The TGA's enforcement actions around unapproved peptides have targeted synthetic, injectable peptides — particularly those marketed for body composition or performance purposes — that do not hold approval as therapeutic goods in Australia. Collagen peptides are food-derived, orally consumed, and typically regulated as food ingredients or listed complementary medicines, not as scheduled or controlled substances. They are a distinct peptide class with a very different regulatory and clinical profile.